US Courts On-site Drug Laboratory - RFI
ID: USCA25RFIType: Sources Sought
Overview

Buyer

ADMINISTRATIVE OFFICE OF THE US COURTSADMINISTRATIVE OFFICE OF THE US COURTSAOUSC-PROCUREMENT MANAGEMENT DIVWASHINGTON, DC, 20002, USA

NAICS

Testing Laboratories and Services (541380)

PSC

MEDICAL- LABORATORY TESTING (Q301)
Timeline
    Description

    The Administrative Office of the U.S. Courts is seeking qualified contractors to provide on-site drug testing laboratory services through a Request for Information (RFI) aimed at gathering market insights for an upcoming procurement. The primary objective is to establish an Indefinite Delivery/Indefinite Quantity (IDIQ) contract that includes the supply and installation of automated analyzers, necessary consumables, maintenance, training, and a data management system across 14 laboratories, ensuring compliance with federal regulations and efficient testing operations. This initiative is crucial for enhancing the drug testing capabilities of the Federal Probation and Pretrial Services system, thereby improving monitoring and rehabilitation efforts for individuals under federal supervision. Interested vendors should submit their responses, including company information and any questions regarding the draft Statement of Work, by 3:00 PM (Eastern) on November 22, 2024, to the primary contacts AJ Lee and LeAnna Stith via their provided email addresses.

    Point(s) of Contact
    Files
    Title
    Posted
    The U.S. Courts seek to establish an on-site drug testing laboratory utilizing an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide comprehensive urine testing for individuals under federal supervision. This contract will include the provision of automated analyzers, consumables, reagents, maintenance, training, and a data management system across various laboratories in the contiguous U.S. and territories. Contractors must ensure that all equipment complies with federal regulations and facilitates efficient testing, achieving specific volumes as outlined per laboratory requirements. Quality control and maintenance protocols will be rigorously established to ensure reliability in testing operations. Additionally, the contractor must deliver new equipment, conduct initial and ongoing training, and provide monthly reports on testing activities, adherence to safety standards, and performance metrics. The overarching goal is to enhance the drug testing capabilities of the Federal Probation and Pretrial Services system while ensuring efficient operations and compliance with applicable regulations. This initiative reflects the government’s commitment to the effective management of substance abuse issues among individuals involved with the judicial system, facilitating better monitoring and rehabilitation efforts.
    Lifecycle
    Title
    Type
    Sources Sought
    Similar Opportunities
    Urinalysis Lab CPRR - Keesler AFB, MS
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking proposals for a Urinalysis Lab system at Keesler Air Force Base in Mississippi. The procurement involves one fully automated urine chemistry analyzer and one microscopic analyzer, along with a backup chemistry analyzer, all under a lease agreement for a five-year period. This equipment is crucial for conducting approximately 900 UA chemistry tests and 700 microscopic exams monthly, ensuring high standards in laboratory testing capabilities within military healthcare. Interested vendors must submit their proposals by January 9, 2025, and can direct inquiries to Carolynn Benn at carolynn.j.benn.civ@health.mil or David Erpelding at david.k.erpelding.civ@health.mil.
    Civilian Drug Free Workplace and Medical Review Officer (MRO) Support Services
    Active
    Dept Of Defense
    The Department of Defense, through the Washington Headquarters Services (WHS), is soliciting proposals for Civilian Drug Free Workplace and Medical Review Officer (MRO) Support Services under NAICS code 621511 - Medical Laboratories. The objective of this procurement is to secure comprehensive support services that ensure compliance with drug-free workplace policies and provide medical review officer expertise, which are critical for maintaining workplace safety and health standards. This solicitation is categorized as unrestricted Full and Open, following FAR Part 12 and FAR Part 15 procedures, and interested parties can find further details in the attached Request for Proposal (RFP) documents. For inquiries, potential bidders may contact Lawan Ferguson at lawan.d.ferguson.civ@mail.mil or call 703-545-1252.
    FDA Regulated Products Sampling Services
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified vendors to provide Sampling Services for FDA-regulated products through a Sources Sought Notice (Ref No. 75F40125R00032). The primary objective of this procurement is to identify capable businesses that can collect physical samples of food, drugs, medical devices, and other products for laboratory analysis, ensuring safety and verifying labeling accuracy. This initiative is crucial for the FDA's regulatory oversight, as it supports the monitoring of product safety and quality, which may include both domestic and imported goods. Interested parties must submit their responses by January 9, 2025, and can contact Amanda Lusk at Amanda.Lusk@fda.hhs.gov or Nicholas Bisher at Nicholas.Bisher@fda.hhs.gov for further information.
    U.S. Customs and Border Protection (CBP) Office of Trade (OT) Trade Regulatory Audit (TRA) Directorate Forensic Audit Services Sources Sought
    Active
    Homeland Security, Department Of
    The U.S. Customs and Border Protection (CBP) Office of Trade is seeking information from vendors capable of providing forensic audit services to support its Trade Regulatory Audit (TRA) Directorate. The primary objectives include enhancing the forensic auditing process through automation, improved analytics, and specialized training for TRA personnel, with a focus on identifying trade violations such as money laundering and forced labor. This initiative is critical for enforcing trade laws, protecting American businesses, and ensuring economic security. Interested parties must submit their responses by 10 AM ET on January 15, 2025, to Jared A. Tritle at jared.a.tritle@cbp.dhs.gov, and should include their capabilities, experience, and relevant company information.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.
    Request for Information (RFI): Insider Threat Program Technical Solutions
    Active
    Justice, Department Of
    The Department of Justice (DOJ) is issuing a Request for Information (RFI) to gather insights from qualified vendors specializing in technology solutions for Insider Threat Programs. The DOJ seeks to understand vendor capabilities in areas such as artificial intelligence, user behavior analytics, and data loss prevention, with the aim of enhancing its proactive measures against insider threats that could compromise sensitive information and national security. This initiative is part of the DOJ's broader commitment to cybersecurity and threat mitigation, and interested vendors must submit their responses, including a Vendor Information Template and Technical Capabilities Matrix, by January 24, 2025. For further inquiries, vendors can contact DeChanta Vaughan or Sar McClain at ITP@usdoj.gov.
    FCI Ray Brook - Alcoholism & Substance Abuse Program
    Active
    Justice, Department Of
    The Department of Justice, specifically the Federal Bureau of Prisons, is preparing to solicit proposals for an Alcoholism & Substance Abuse Program aimed at federal offenders incarcerated at the Federal Correctional Institution (FCI) Ray Brook in New York. This procurement will involve an indefinite delivery/requirements contract with firm-fixed unit pricing, covering a base period of 12 months with four optional one-year renewals at the government's discretion. The program is critical for addressing substance abuse issues among inmates, contributing to their rehabilitation and reintegration into society. Interested parties should monitor the SAM.gov website for the forthcoming solicitation, expected to be released around January 6, 2025, with quotes due approximately by January 17, 2025. For further inquiries, potential bidders can contact Sarah Burke at sburke@bop.gov.
    REQUEST FOR INFORMATION METABOLOMICS ANALYSIS SERVICES
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking information from qualified vendors for specialized metabolomics analysis services to support ongoing research at the United States Army Medical Research Institute of Environmental Medicine (USARIEM). The procurement aims to obtain both untargeted and targeted metabolomics measurements from various human biological samples, including urine, blood, feces, saliva, and tissue, necessitating advanced laboratory capabilities such as ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). This initiative is critical for enhancing the understanding of metabolic functions and nutritional status within military health studies. Interested parties must submit their qualifications, including business size and capabilities, by January 7, 2025, to Kasey Carroll at kasey.l.carroll.civ@health.mil, as responses are voluntary and will not result in a binding contract.
    Second Chance Act Goods and Services Pre-Solicitation Notice
    Active
    Administrative Office Of The Us Courts
    Presolicitation notice: ADMINISTRATIVE OFFICE OF THE US COURTS is seeking goods and services related to Outpatient Mental Health and Substance Abuse Centers. The federal Judiciary intends to procure treatment services and/or Second Chance Act goods and services for federal defendants and persons under supervision using Blanket Purchase Agreements. The services may include urine collection, counseling, physical examinations, detoxification, residential treatment, and transportation. The goods and services may include cognitive behavioral therapy, child-care, medical services, computer hardware/software, identification, transportation, transitional housing, domestic violence intervention, and job training. The specific services and requirements will be identified in the solicitation for Blanket Purchase Agreements.
    QIACube Maintenance Agreement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for a maintenance agreement for its QIACube system, essential for the Atlanta Human and Animal Food Laboratory's molecular biology operations. The procurement requires a comprehensive service agreement that includes repair, labor, travel, and a loaner instrument, ensuring compliance with ISO accreditation standards and continuity in critical DNA and RNA extraction processes. The contract will commence on February 1, 2025, and run for one year, with options for four additional years, and proposals are due by 11:59 PM EST on January 3, 2025. Interested vendors can contact James O’Keefe at 301-796-7371 or via email at James.OKeefeIII@fda.hhs.gov for further information.